Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 USD | +5.42% | +2.88% | -0.23% |
Financials (USD)
Sales 2024 * | 62.7M | Sales 2025 * | 71M | Capitalization | 20.26M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -9M | EV / Sales 2024 * | 0.32 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.29 x |
P/E ratio 2024 * |
-0.99
x | P/E ratio 2025 * |
-2.06
x | Employees | 380 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.35% |
Latest transcript on Trinity Biotech plc
1 day | +5.42% | ||
1 week | +2.88% | ||
Current month | +0.47% | ||
1 month | +29.70% | ||
3 months | +9.18% | ||
6 months | -2.62% | ||
Current year | -0.23% |
Managers | Title | Age | Since |
---|---|---|---|
John Gillard
CEO | Chief Executive Officer | 43 | 20-11-16 |
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Eibhlin Kelly
CTO | Chief Tech/Sci/R&D Officer | 40 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Jim Walsh
BRD | Director/Board Member | 65 | 95-09-30 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 2.14 | +5.42% | 19 224 |
24-07-02 | 2.03 | -7.73% | 39,889 |
24-07-01 | 2.2 | +3.29% | 15,827 |
24-06-28 | 2.13 | +2.40% | 36,215 |
24-06-27 | 2.08 | +0.97% | 36,653 |
Delayed Quote Nasdaq, July 03, 2024 at 01:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.23% | 19.21M | |
-10.29% | 11.38B | |
-20.75% | 6.83B | |
+5.45% | 5.52B | |
+28.32% | 5.44B | |
-21.94% | 3.62B | |
+6.32% | 2.56B | |
-66.49% | 2.26B | |
+30.36% | 2.24B | |
-12.28% | 2.13B |
- Stock Market
- Equities
- TRIB Stock